Table 1 Echocardiographic results for the WT, HDC−/−, and STAT6−/− mice at baseline.

From: Aggravated myocardial infarction-induced cardiac remodeling and heart failure in histamine-deficient mice

 

WT Sham

HDC−/− Sham

STAT6−/− Sham

LVEF (%)

76.82 ± 4.92

73.08 ± 8.10

75.75 ± 4.38

LVFS (%)

44.77 ± 4.35

42.30 ± 6.75

44.66 ± 4.97

LVESD (mm)

2.06 ± 0.32

2.11 ± 0.30

2.00 ± 0.28

LVEDD (mm)

3.52 ± 0.22

3.65 ± 0.11

3.48 ± 0.31

LVESV (μl)

16.53 ± 3.00

16.21 ± 3.05

16.14 ± 2.64

LVEDV (μl)

52.62 ± 4.05

58.86 ± 5.47

52.25 ± 4.75

LVDAW (mm)

0.85 ± 0.13

0.83 ± 0.12

0.81 ± 0.09

LVSAW (mm)

1.24 ± 0.12

1.20 ± 0.14

1.19 ± 0.11

  1. LVEF: left ventricular ejection fraction; LVFS: left ventricular fractional shortening; LVESD: left ventricular end-systolic diameter; LVEDD: left ventricular end-diastolic diameter; LVESV: left ventricular end-systolic volume; LVEDV: left ventricular end-diastolic volume; LVDAW: left ventricular diastolic anterior wall thickness; LVSAW: left ventricular systolic anterior wall thickness. n = 6.